VanEck Pharmaceutical ETF PPH
121.25 USD +2.42 (+2.04%)
At closeNov 9, 2026, 4:00 PM EST
121.25 0.00 0.00%
After hours · Nov 9, 4:00 PM ET
119.31 Day range 121.55
94.24 52-week range 123.53
- YTD
- +17.52%
- 1 year
- +29.14%
- Market cap
- 1.10B
- EPS (ttm)
- 4.29
- P/E ratio
- 28.30
- YTD return
- +17.52%
- 1-year return
- +29.14%
- Volume
- 344.86K
- Avg volume
- 321.98K
- Open
- 120.12
- Previous close
- 118.83
- Day's range
- 119.31 – 121.55
- 52-week range
- 94.24 – 123.53
5D +1.39 (+1.16%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 112.93
- 200-day average
- 108.26
About VanEck Pharmaceutical ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on PPH — it syncs with the Stock Master app.